Frazier Life Sciences VIII, L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Frazier Life Sciences VIII, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Frazier Life Sciences VIII, L.P.. Frazier Life Sciences VIII, L.P. is 10% Owner in ALPINE IMMUNE SCIENCES, INC. ($ALPN) and 10% Owner in Aptinyx Inc. ($APTX) and 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX) and 10% Owner in Arcutis Biotherapeutics, Inc. ($ARQT).
Latest Insider Trading Transactions of Frazier Life Sciences VIII, L.P.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, APTX, ARQT, ETTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2021 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Sell | J | 0.00 | 96,574 | 0 | 0 | 96.6 K to 0 (-100.00 %) |
| May 12 2021 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | J | 0.00 | 96,574 | 0 | 96,574 | 0 to 96.6 K |
| May 12 2021 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Sell | J | 0.00 | 2,108,558 | 0 | 8,434,232 | 10.5 M to 8.4 M (-20.00 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,074,467 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 2,099,019 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 6,360,272 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | P | 17.00 | 500,000 | 8,500,000 | 10,542,790 | 10 M to 10.5 M (+4.98 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 1,074,467 | 0 | 10,042,790 | 9 M to 10 M (+11.98 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 2,099,019 | 0 | 8,968,323 | 6.9 M to 9 M (+30.56 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 6,360,272 | 0 | 6,869,304 | 509 K to 6.9 M (+1,249.48 %) |
| Jan 13 2020 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Sell | S | 5.00 | 50,000 | 250,010 | 1,299,953 | 1.3 M to 1.3 M (-3.70 %) |
| Jan 22 2019 | ALPN | ALPINE IMMUNE SCIE ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | P | 12.74 | 145,251 | 1,850,498 | 145,251 | |
| Jan 22 2019 | ALPN | ALPINE IMMUNE SCIE ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | P | 5.37 | 372,439 | 1,999,997 | 2,571,450 | 2.2 M to 2.6 M (+16.94 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 6,651,574 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 5,212,833 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | P | 15.00 | 375,887 | 5,638,305 | 1,349,953 | 974.1 K to 1.3 M (+38.59 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 320,898 | 0 | 974,066 | 653.2 K to 974.1 K (+49.13 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 251,487 | 0 | 589,194 | 337.7 K to 589.2 K (+74.47 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 337,707 | 0 | 337,707 | 0 to 337.7 K |
| Jun 26 2018 | APTX | Aptinyx Inc. | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 21,946,301 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 33,022,786 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 28,895,188 | 0 | 0 | |
| Jun 26 2018 | APTX | Aptinyx Inc. | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | P | 16.00 | 150,000 | 2,400,000 | 3,190,079 | 3 M to 3.2 M (+4.93 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 795,553 | 0 | 3,040,079 | 2.2 M to 3 M (+35.44 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 1,197,076 | 0 | 2,244,526 | 1 M to 2.2 M (+114.28 %) |
| Jun 26 2018 | APTX | Aptinyx Inc. | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 1,047,450 | 0 | 1,047,450 | 0 to 1 M |
Page: 1